Opsens Inc (OPSSF) 0.6670 $OPSSF
Opsens Presentation Now Available for On-Demand Viewing
CNW Group - Tue Oct 06, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV:OPS) (OTCQX:OPSSF), a company focusing on the measure of Fractional Flow Reserve ("FFR" in interventional cardiology, today announced that the October 1 presentation from Louis Laflamme, President and Chief Executive Officer, is now available for on-demand viewing at VirtualInvestorConferences.com. During this presentation, Mr. Laflamme provides a corporate overview, including recent development on the Company.
OPS.VN: 0.860 (+0.060)
Opsens to Present Live Via Webcast at VirtualInvestorConferences.com on October 1, 2015 at 9:15am ET
PR Newswire - Tue Sep 29, 10:36AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF), a company focusing on the measure of Fractional Flow Reserve ("FFR" in interventional cardiology, announced today that Louis Laflamme, President and Chief Executive Officer, will present at VirtualInvestorConferences.com hosted by the OTC Markets Group, on Thursday, October 1, 2015, at 9:15 a.m. ET.
OPS.VN: 0.860 (+0.060)
OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1
PR Newswire - Mon Sep 28, 8:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets for 10,000 U.S. and global securities, today announced its second in a series of online investor conferences for companies traded on the OTCQX® Best Market through its partnership with VirtualInvestorConferences.com, a cooperative venture of PR Newswire and Better Investing(TM).
Opsens hires Tony Gibbons as Vice President, Sales and Marketing
CNW Group - Wed Sep 16, 8:36AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) is pleased to announce the hiring of Tony Gibbons as Vice President, Sales and Marketing. He will be responsible for the global commercialization plan for Opsens' products intended to measure Fractional Flow Reserve ("FFR" . Opsens' FFR Products, the OptoWire and OptoMonitor, are designed to optimize the diagnostic and guide treatment in patients with coronary heart disease.
BSX: 16.88 (+0.09), OPS.VN: 0.860 (+0.060)
Opsens announces the resignation of a director
CNW Group - Wed Sep 16, 8:26AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV:OPS) (OTCQX:OPSSF) announces the resignation of Lucien Goffart. As part of the progression of his career, Mr. Goffart is now involved in projects that are incompatible with his Director's responsibilities at Opsens.
OPS.VN: 0.860 (+0.060)
Opsens Announces a Reorganization of its Corporate Structure
CNW Group - Thu Sep 03, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) is pleased to announce the reorganization of its corporate structure.
OPS.VN: 0.860 (+0.060)
OPSENS announces an Energy Sector partnership with precise downhole services
CNW Group - Fri Aug 28, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) is pleased to announce a partnership agreement between Opsens Solutions Inc. ("Opsens Solutions" , a wholly-owned subsidiary of Opsens and Precise Downhole Services Ltd. ("Precise DHS" for the installation of its products for the Oil and Gas market in Western Canada.
OPS.VN: 0.860 (+0.060)
Global Coronary Guidewires Pipeline Report 2015
M2 - Wed Jul 22, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5jnt7x/coronary) has announced the addition of the "Coronary Guidewires - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Guidewires pipeline products. Scope - Extensive coverage of the Coronary Guidewires under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Coronary Guidewires - Pipeline Products under Development by Companies 5 Coronary Guidewires Companies and Product Overview 6 Coronary Guidewires- Recent Developments 7 Appendix Companies Mentioned - Boston Scientific Corporation - Computer Vision Systems Laboratories Corp. - Guided Interventions LLC - MaRVis Technologies GmbH - MicroPort Scientific Corporation - Occlutech International AB - Opsens Inc. - The Cleveland Clinic Foundation For more information visit http://www.researchandmarkets.com/research/5jnt7x/coronary
BSX: 16.88 (+0.09)
Opsens receives Health Canada approval to commercialize its FFR products
CNW Group - Tue Jul 21, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) today announced it has received Health Canada's approval to commercialize the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve ("FFR" . FFR is used to optimize the diagnosis and guide the treatment of patients with coronary heart disease.
OPS.VN: 0.860 (+0.060)
United States Biomedical Sensors Market 2015 - Growth, Trends & Forecasts 2014-2020 for the $4.5 Billion Industry
M2 - Thu Jul 02, 10:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bxv696/us_biomedical) has announced the addition of the "US Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The US Biomedical Sensors market is estimated at $4.50 billion by 2018 at a CAGR of 7.43% over the period 2014-2020 The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/bx...biomedical
HNSN: 4.21 (-0.03)
Russia Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 10:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vm5z2t/russia_biomedical) has announced the addition of the "Russia Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Russia Biomedical Sensors market is estimated at $0.25 billion by 2018 at a CAGR of 2.94% over the period 2014-2020. The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/vm...biomedical
HNSN: 4.21 (-0.03)
Italy Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hktjw9/italy_biomedical) has announced the addition of the "Italy Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Italy Biomedical Sensors market is estimated at $0.17 billion by 2018 at a CAGR of 0.54% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/hk...biomedical
HNSN: 4.21 (-0.03)
Opsens - Results for third quarter 2015
CNW Group - Thu Jul 02, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) today released results for its third quarter ended May 31, 2015.
OPS.VN: 0.860 (+0.060)
OPSENS Moves FFR Activities to Increase Manufacturing Capacity
CNW Group - Thu Jun 25, 9:00AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) announces that in light of the positive feedback on the performance of its products developed to measure Fractional Flow Reserve ("FFR" , the OptoWire and OptoMonitor ("Opsens' FFR products" , and the recent FDA approval for the commercialization of these products in the U.S., the Company is going forward with a massive expansion to increase the manufacturing capacity and accommodate its growing number of employees.
OPS.VN: 0.860 (+0.060)
Latin America Biomedical Sensors Market 2015-2020: Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) & Applications (Pharmaceutical, Healthcare)
M2 - Wed Jun 24, 3:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4x8wr/latin_america) has announced the addition of the "Latin America Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Latin America Biomedical Sensors market is estimated at $0.65 billion by 2018 at a CAGR of 2.04% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Mexico closely followed by Brazil account for highest market share with Brazil projecting a higher growth rate over the forecasted period. The Latin America Biomedical Sensors Market is segmented on the basis of Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical), Application (Pharmaceutical, Healthcare). Company Profiles - Zephyr Technology Corp. - Entra Health Systems - FISO Technologies Inc. - LumaSense Technologies - Neoptix - Opsens,Inc. - RJC Enterprises LLC - Infraredx, Inc. - ISS, Inc. - SRICO - ADInstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/w4...in_america
HNSN: 4.21 (-0.03)
IIROC Trade Resumption - Opsens Inc.
Newsfile Corp - Mon Jun 15, 10:47AM CDT
Trading resumes in:
OPSENS gets clearance to sell FFR products in the United States
CNW Group - Mon Jun 15, 10:26AM CDT
Opsens Inc. (TSXV:OPS) (OTCQX:OPSSF) ("Opsens" or the "Company" today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve ("FFR" . This measure is used to optimize the diagnostic and guide the treatment of patients with coronary heart disease. This clearance gives Opsens permission to sell its FFR products in the United States, the world's largest FFR market.
OPS.VN: 0.860 (+0.060)
IIROC Trade Halt - Opsens Inc.
Newsfile Corp - Mon Jun 15, 7:02AM CDT
The following issues have been halted by IIROC:
Opsens Presentation Now Available for On-Demand Viewing
CNW Group - Tue Oct 06, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV:OPS) (OTCQX:OPSSF), a company focusing on the measure of Fractional Flow Reserve ("FFR" in interventional cardiology, today announced that the October 1 presentation from Louis Laflamme, President and Chief Executive Officer, is now available for on-demand viewing at VirtualInvestorConferences.com. During this presentation, Mr. Laflamme provides a corporate overview, including recent development on the Company. OPS.VN: 0.860 (+0.060)
Opsens to Present Live Via Webcast at VirtualInvestorConferences.com on October 1, 2015 at 9:15am ET
PR Newswire - Tue Sep 29, 10:36AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF), a company focusing on the measure of Fractional Flow Reserve ("FFR" in interventional cardiology, announced today that Louis Laflamme, President and Chief Executive Officer, will present at VirtualInvestorConferences.com hosted by the OTC Markets Group, on Thursday, October 1, 2015, at 9:15 a.m. ET. OPS.VN: 0.860 (+0.060)
OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1
PR Newswire - Mon Sep 28, 8:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets for 10,000 U.S. and global securities, today announced its second in a series of online investor conferences for companies traded on the OTCQX® Best Market through its partnership with VirtualInvestorConferences.com, a cooperative venture of PR Newswire and Better Investing(TM).
Opsens hires Tony Gibbons as Vice President, Sales and Marketing
CNW Group - Wed Sep 16, 8:36AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) is pleased to announce the hiring of Tony Gibbons as Vice President, Sales and Marketing. He will be responsible for the global commercialization plan for Opsens' products intended to measure Fractional Flow Reserve ("FFR" . Opsens' FFR Products, the OptoWire and OptoMonitor, are designed to optimize the diagnostic and guide treatment in patients with coronary heart disease. BSX: 16.88 (+0.09), OPS.VN: 0.860 (+0.060)
Opsens announces the resignation of a director
CNW Group - Wed Sep 16, 8:26AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV:OPS) (OTCQX:OPSSF) announces the resignation of Lucien Goffart. As part of the progression of his career, Mr. Goffart is now involved in projects that are incompatible with his Director's responsibilities at Opsens. OPS.VN: 0.860 (+0.060)
Opsens Announces a Reorganization of its Corporate Structure
CNW Group - Thu Sep 03, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) is pleased to announce the reorganization of its corporate structure. OPS.VN: 0.860 (+0.060)
OPSENS announces an Energy Sector partnership with precise downhole services
CNW Group - Fri Aug 28, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) is pleased to announce a partnership agreement between Opsens Solutions Inc. ("Opsens Solutions" , a wholly-owned subsidiary of Opsens and Precise Downhole Services Ltd. ("Precise DHS" for the installation of its products for the Oil and Gas market in Western Canada. OPS.VN: 0.860 (+0.060)
Global Coronary Guidewires Pipeline Report 2015
M2 - Wed Jul 22, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5jnt7x/coronary) has announced the addition of the "Coronary Guidewires - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Guidewires pipeline products. Scope - Extensive coverage of the Coronary Guidewires under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Coronary Guidewires - Pipeline Products under Development by Companies 5 Coronary Guidewires Companies and Product Overview 6 Coronary Guidewires- Recent Developments 7 Appendix Companies Mentioned - Boston Scientific Corporation - Computer Vision Systems Laboratories Corp. - Guided Interventions LLC - MaRVis Technologies GmbH - MicroPort Scientific Corporation - Occlutech International AB - Opsens Inc. - The Cleveland Clinic Foundation For more information visit http://www.researchandmarkets.com/research/5jnt7x/coronary
BSX: 16.88 (+0.09)
Opsens receives Health Canada approval to commercialize its FFR products
CNW Group - Tue Jul 21, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) today announced it has received Health Canada's approval to commercialize the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve ("FFR" . FFR is used to optimize the diagnosis and guide the treatment of patients with coronary heart disease. OPS.VN: 0.860 (+0.060)
United States Biomedical Sensors Market 2015 - Growth, Trends & Forecasts 2014-2020 for the $4.5 Billion Industry
M2 - Thu Jul 02, 10:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bxv696/us_biomedical) has announced the addition of the "US Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The US Biomedical Sensors market is estimated at $4.50 billion by 2018 at a CAGR of 7.43% over the period 2014-2020 The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/bx...biomedical
HNSN: 4.21 (-0.03)
Russia Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 10:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vm5z2t/russia_biomedical) has announced the addition of the "Russia Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Russia Biomedical Sensors market is estimated at $0.25 billion by 2018 at a CAGR of 2.94% over the period 2014-2020. The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/vm...biomedical
HNSN: 4.21 (-0.03)
Italy Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hktjw9/italy_biomedical) has announced the addition of the "Italy Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Italy Biomedical Sensors market is estimated at $0.17 billion by 2018 at a CAGR of 0.54% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/hk...biomedical
HNSN: 4.21 (-0.03)
Opsens - Results for third quarter 2015
CNW Group - Thu Jul 02, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) today released results for its third quarter ended May 31, 2015. OPS.VN: 0.860 (+0.060)
OPSENS Moves FFR Activities to Increase Manufacturing Capacity
CNW Group - Thu Jun 25, 9:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) announces that in light of the positive feedback on the performance of its products developed to measure Fractional Flow Reserve ("FFR" , the OptoWire and OptoMonitor ("Opsens' FFR products" , and the recent FDA approval for the commercialization of these products in the U.S., the Company is going forward with a massive expansion to increase the manufacturing capacity and accommodate its growing number of employees. OPS.VN: 0.860 (+0.060)
Latin America Biomedical Sensors Market 2015-2020: Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) & Applications (Pharmaceutical, Healthcare)
M2 - Wed Jun 24, 3:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4x8wr/latin_america) has announced the addition of the "Latin America Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Latin America Biomedical Sensors market is estimated at $0.65 billion by 2018 at a CAGR of 2.04% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Mexico closely followed by Brazil account for highest market share with Brazil projecting a higher growth rate over the forecasted period. The Latin America Biomedical Sensors Market is segmented on the basis of Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical), Application (Pharmaceutical, Healthcare). Company Profiles - Zephyr Technology Corp. - Entra Health Systems - FISO Technologies Inc. - LumaSense Technologies - Neoptix - Opsens,Inc. - RJC Enterprises LLC - Infraredx, Inc. - ISS, Inc. - SRICO - ADInstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/w4...in_america
HNSN: 4.21 (-0.03)
IIROC Trade Resumption - Opsens Inc.
Newsfile Corp - Mon Jun 15, 10:47AM CDT
Trading resumes in:
OPSENS gets clearance to sell FFR products in the United States
CNW Group - Mon Jun 15, 10:26AM CDT
Opsens Inc. (TSXV:OPS) (OTCQX:OPSSF) ("Opsens" or the "Company"
today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve ("FFR" . This measure is used to optimize the diagnostic and guide the treatment of patients with coronary heart disease. This clearance gives Opsens permission to sell its FFR products in the United States, the world's largest FFR market. OPS.VN: 0.860 (+0.060)
IIROC Trade Halt - Opsens Inc.
Newsfile Corp - Mon Jun 15, 7:02AM CDT
The following issues have been halted by IIROC:
